Noticias de IONS_US
Noticias del mercado
Últimas noticias sobre IONS_US — 420 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
The U.S. FDA has approved Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)’s Zanvastro (zilganersen) as the first FDA-approved treatment for Alexander disease (AxD), a rare, progressive neurological disorder caused by mutations in the GFAP gene. The disease affects fewer than 1,000 people in the U.S. and can lead to seizures, loss of developmental milestones, impaired movement, and other […]
Zanvastro is now approved for children and adults with Alexander disease, a rare and often fatal brain condition that affects fewer than one in a million people.
Vea los precios de cotización de acciones de Ionis Pharmaceuticals, Inc. IONS, información financiera, pronósticos en tiempo real y noticias de la compañía de CNN.
Price-action only: Ionis Pharmaceuticals Inc. (IONS) movements set the tone for institutional models. Trading Systems Reacting to (IONS) Volatility
Página 2 de 21